Europe’s healthcare M&A is poised to maintain strong momentum in 2026 following this year’s rebound in deal activity and renewed market confidence. “The sector is in a flywheel of productivity with drivers including ageing populations, workforce shortages, and technology adoption,” said Lloyd Price, Partner at Nelson Advisors. Following the turbulent tariff and regulatory environment at the start of 2025, the market is entering a period of relative confidence, he added.